高等学校化学学报 ›› 2016, Vol. 37 ›› Issue (8): 1451.doi: 10.7503/cjcu20160222

• 有机化学 • 上一篇    下一篇

间接糖基化马蹄金素衍生物的合成及抗乙肝病毒活性研究

徐广灿1,2, 袁洁1,4, 刘青川3, 黄正明3, 梁光义1,2(), 徐必学1()   

  1. 1. 贵州省中国科学院天然产物化学重点实验室, 贵阳 550002
    2. 贵阳中医学院药学院, 贵阳 550002
    3. 中国人民解放军第三○二医院, 北京 100039
    4. 新疆医科大学厚博学院, 克拉玛依 834000
  • 收稿日期:2016-05-20 出版日期:2016-07-19 发布日期:2016-07-19
  • 作者简介:

    联系人简介: 梁光义, 男, 博士, 教授, 博士生导师, 主要从事天然产物化学方面的研究. E-mail: guangyi_liang@126.com. 徐必学, 男, 博士, 副研究员, 主要从事药物化学方面的研究. E-mail: bixue_xu@126.com

  • 基金资助:
    国家自然科学基金(批准号: 81360472)资助

Synthesis and Anti-HBV Activities of the Indirect Galactopyranosyl Derivatives of Matijin-Su

XU Guangcan1,2, YUAN Jie1,4, LIU Qingchuan3, HUANG Zhengming3, LIANG Guangyi1,2,*(), XU Bixue1,*()   

  1. 1. The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences,Guiyang 550002, China
    2. College of Pharmacy, Guiyang College of Traditional Chinese Medicine, Guiyang 550002, China
    3. 302 Hospital of PLA, Beijing 100039, China
    4. HouBo College of Xinjiang Medical University, Karamay 834000, China
  • Received:2016-05-20 Online:2016-07-19 Published:2016-07-19
  • Contact: LIANG Guangyi,XU Bixue E-mail:guangyi_liang@126.com;bixue_xu@126.com
  • Supported by:
    Supported by the National Natural Science Foundation of China(No.81360472)

摘要:

以二缩三乙二醇或三缩四乙二醇为连接臂, 通过间接引入具有肝靶向性的D-半乳糖配基的方法, 设计合成了6个半乳糖糖基化修饰的肝靶向马蹄金素(MTS)衍生物; 通过1H NMR, 13C NMR, 1H-1H COSY, HMQC和ESI-MS对其结构进行了表征; 并以HepG2 2.2.15为细胞模型初步评价了目标化合物的抗乙肝病毒(HBV)活性. 结果表明, 所有目标化合物对HBV DNA的复制均有抑制作用, 且具有一定的量效关系. 化合物15b的体外抗HBV活性最好, 后期研究将选用其进行小鼠体内组织分布实验, 并与原型化合物以及Y101体内组织分布情况进行比较研究, 以验证半乳糖基的引入能否提高MTS衍生物的肝靶向性.

关键词: 肝靶向, 半乳糖, 马蹄金素衍生物, 抗HBV活性

Abstract:

To explore the effect of the length of the linker on the activities of the derivatives of Matijin-Su(MTS) with potential for hepatic targeting, six galactosyl derivatives of MTS with potential for hepatic targeting were synthesized by binding galactosyl to derivatives of MTS using triethylene glycol or tetraethylene glycol as a linking arm, and their structures were confirmed by means of 1H NMR, 13C NMR, 1H-1H COSY, HMQC and ESI-MS. The anti-HBV activities of those compounds were evaluated using HepG2 2.2.15 cells. The screening results showed that all the target compounds had inhibitory effect on HBV DNA replication in HepG2 2.2.15 cells in a dose-response manner. The inhibition rates of compounds 15b(72.24%), 15c(56.49%), 15f(65.24%) on the replication of HBV DNA were better than other tested compounds, when the in concentration of the drug was 50 μg/mL. The results can provide reference for further research of hepatic targeting MTS derivatives. For the evaluation of the hepatic target distribution of galactopyranosyl derivatives of MTS, compound 15b with best anti HBV activity will be selected to do tissue distribution experiments in vivo and comparative study with derivative of MTS(13b) and Y101.

Key words: Hepatic targeting, Glacatose, Derivatives of Matijin-Su(MTS), Anti-hepatitis B virus activity

中图分类号: 

TrendMD: